| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3328125 | Acta Haematologica Polonica | 2015 | 7 Pages |
Abstract
In patients with follicular lymphoma (FL), there are several factors influencing the disease course: morphological, immunological, genetic and clinical. The therapeutic options for patients with FL contain many methods such as rituximab with different chemotherapy regimens, radioimmunotherapy, radiotherapy and hematopoietic stem cell transplantation. The modern management of FL patients should consist of personalization of therapy related to risk factors.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Maria Cioch, Karolina Radomska, Paweł Jarosz, Hanna Borowska,